MOLBIO DIAGNOSTICS
MOLBIOVerifiedMOLBIO DIAGNOSTICS is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — MOLBIO DIAGNOSTICS
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
MOLBIO DIAGNOSTICS (MOLBIO) is a Indian equity security listed on the NSE/BSE with ISIN BSE:544866. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹1574.40, recording a +145.10 (+10.15%) advance from its previous close of ₹1429.30. Over the trailing 52-week trading cycle, MOLBIO has traded between a 52-week low of ₹1036.65 and a 52-week high of ₹1574.40, establishing its annual trading channel. In historical performance, MOLBIO DIAGNOSTICS has gained 51.14% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +9.44%, 1-month: +20.46%, 6-month: +51.14%, 1-year: +51.14%, 3-year: +51.14%, 5-year: +51.14%. Daily reported trading volume reached 83,24,984 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 99.5x and a price-to-book (P/B) ratio of 13.9x, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹16,578.43 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.23 | +0.03 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.23% co-movement (correlation: 0.03). Descriptive historical relationship, not predictive. |
| USD / INR | -1.88 | -0.19 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -1.88% co-movement (correlation: -0.19). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | +0.38 | +0.16 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a +0.38% co-movement (correlation: 0.16). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | +0.87 | +0.15 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a +0.87% co-movement (correlation: 0.15). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹1,438.60 | ₹1,574.40 | +9.44% |
| 15 Days | ₹1,513.10 | ₹1,574.40 | +4.05% |
| 1 Month | ₹1,307.00 | ₹1,574.40 | +20.46% |
| 3 Months | ₹1,041.70 | ₹1,574.40 | +51.14% |
| 6 Months | ₹1,041.70 | ₹1,574.40 | +51.14% |
| 1 Year | ₹1,041.70 | ₹1,574.40 | +51.14% |
| 3 Years | ₹1,041.70 | ₹1,574.40 | +51.14% |
| 5 Years | ₹1,041.70 | ₹1,574.40 | +51.14% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹1,041.70 | ₹1,574.40 | +51.1% |
Historical Investment Simulator
Factual simulation of past returns in MOLBIO DIAGNOSTICS (MOLBIO) using real recorded closing prices.
Corporate Actions History
No dividend or stock split distributions recorded in historical feeds for MOLBIO.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Molbio Diagnostics Stock Soars 9% As It Becomes Jefferies Top Med Tech Pick At Initiation - NDTV Profit
Molbio Diagnostics Stock Soars 9% As It Becomes Jefferies Top Med Tech Pick At Initiation NDTV Profit
Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSE - The Economic Times
Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSE The Economic Times
Molbio Diagnostics extends post-listing gains, Dhoot Transmission down after listing at 37% premium: Check... - Moneycontrol.com
Molbio Diagnostics extends post-listing gains, Dhoot Transmission down after listing at 37% premium: Check... Moneycontrol.com
Solid debut! Molbio Diagnostics shares list at 21% premium over IPO price - Business Standard
Solid debut! Molbio Diagnostics shares list at 21% premium over IPO price Business Standard
Molbio Diagnostics (NSE: MOLBIO): Medical Equipment Business Overview and Insights - Kalkine India
Molbio Diagnostics (NSE: MOLBIO): Medical Equipment Business Overview and Insights Kalkine India
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Quarterly financial statements disclosed under statutory SEBI LODR Regulation 33.
- •Direct quantitative change registered at 9%
- •Quarterly financial results disclosed under SEBI LODR Regulation 33
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About MOLBIO DIAGNOSTICS (MOLBIO)
Key facts on MOLBIO share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of MOLBIO DIAGNOSTICS (MOLBIO)?
As of 16 Oct 2026, the official closing share price of MOLBIO DIAGNOSTICS (MOLBIO) on NSE/BSE is ₹1,574.40 (+10.15% vs the previous close). Over the past 52 weeks, MOLBIO has traded between a low of ₹1,036.65 and a high of ₹1,574.40, with a reported market capitalization of ₹16,578.43 Cr.
What are the historical returns of MOLBIO DIAGNOSTICS (MOLBIO)?
Based on split-adjusted closing prices through 16 Oct 2026, MOLBIO DIAGNOSTICS (MOLBIO) recorded the following trailing price returns: 1 Week: +9.44% (from ₹1,438.60 to ₹1,574.40); 15 Days: +4.05% (from ₹1,513.10 to ₹1,574.40); 1 Month: +20.46% (from ₹1,307.00 to ₹1,574.40); 3 Months: +51.14% (from ₹1,041.70 to ₹1,574.40); 6 Months: +51.14% (from ₹1,041.70 to ₹1,574.40); 1 Year: +51.14% (from ₹1,041.70 to ₹1,574.40); 3 Years: +51.14% (from ₹1,041.70 to ₹1,574.40); 5 Years: +51.14% (from ₹1,041.70 to ₹1,574.40). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of MOLBIO DIAGNOSTICS (MOLBIO)?
MOLBIO DIAGNOSTICS (MOLBIO) currently trades at a trailing Price-to-Earnings (P/E) ratio of 99.5x, a Price-to-Book (P/B) ratio of 13.9x, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in MOLBIO have grown?
Based on historical closing prices for MOLBIO DIAGNOSTICS (MOLBIO): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹1,51,137.57 (+51.1% total return, 1135.8% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹30,000.00) would be worth ₹40,466.19 (+34.9% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.